未登录GLIOMA PATHOLOGICAL DISTRIBUTIONS BASED ON THE 2021 WHO CLASSIFICATION AND 3-YEAR SURVIVAL OUTCOMES: A MULTI-CENTER COHORT FROM NATIONAL BRAIN TUMOR REGISTRY OF CHINA (NBTRC)基于2021年WHO分类的胶质瘤病理分布及3年生存结局：一项来自中国国家脑肿瘤登记系统（NBTRC）的多中心队列研究
Shi, S.; Hu, Z.; Zhao, X.; Geng, J.; Yang, H.; Xing, H.; Qi, J.; Xiao, D.; Zhou, M.; Li, D. .png)
分享.png)
收藏分享 收藏 分享 收藏 Sirtuin1 Suppresses Calcium Oxalate Nephropathy via Inhibition of Renal Proximal Tubular Cell Ferroptosis Through PGC-1α-mediated Transcriptional CoactivationDuan, Chen; Li, Bo; Liu, Haoran; Zhang, Yangjun; Yao, Xiangyang; Liu, Kai; Wu, Xiaoliang; Mao, Xiongmin; Wu, Huahui; Xu, Zhenzhen; Zhong, Yahua; Hu, Zhiquan; Gong, Yan; Xu, Hua 分享 收藏 分享 收藏 分享 收藏 Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinomaTian, Jihua; Luo, Jing; Zeng, Xing; Ke, Chunjin; Wang, Yanan; Liu, Zhenghao; Li, Le; Zhang, Yangjun; Hu, Zhiquan; Yang, Chunguang 分享 收藏 分享 收藏 分享 收藏 China ARCHES: A multicenter phase III randomized doubleblind placebo (PBO)-controlled efficacy and safety trial of enzalutamide (ENZA) plus androgen deprivation therapy (ADT) vs PBO plus ADT in Chinese patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC)Zhou, F.; Gongqian, Z.; Guo, H.; Hu, Z.; Zhang, X.; He, D.; He, Z.; Zhang, D.; Li, Y.; Kadeerbai, H.; Liu, Y.; Ye, D. 分享 收藏 Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumors鉴定与临床特征相关的选择性剪接: 从泛癌症到泌尿生殖系统肿瘤Duan, Chen; Zhang, Yangjun; Li, Lu; Liu, Kai; Yao, Xiangyang; Wu, Xiaoliang; Li, Bo; Mao, Xiongmin; Wu, Huahui; Liu, Haoran; Zeng, Jin; Li, Sheng; Gong, Yan; Hu, Zhiquan; Xu, Hua 分享 收藏 Targeting Alpha-Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD-1 Blockade Immunotherapy in Renal Cell CarcinomaLi, Le; Zeng, Xing; Chao, Zheng; Luo, Jing; Guan, Wei; Zhang, Qiang; Ge, Yue; Wang, Yanan; Xiong, Zezhong; Ma, Sheng; Zhou, Qiang; Zhang, Junbiao; Tian, Jihua; Horne, David; Yuh, Bertram; Hu, Zhiquan; Wei, Gong-Hong; Wang, Baojun; Zhang, Xu; Lan, Peixiang; Wang, Zhihua 分享 收藏 分享 收藏 Proxalutamide in metastatic castration-resistant prostate cancer: Primary analysis of a multicenter, randomized, open-label, phase 2 trial普罗沙鲁胺治疗转移性去势抵抗性前列腺癌: 一项多中心、随机、开放标签、2期试验的初步分析Zhou, Tie; Qin, Shengfei; Xu, Weidong; Tang, Shouyan; Chen, Guanghua; Li, Song; Hou, Jianguo; Gao, Xu; Shi, Guowei; Sun, Zhongquan; Jin, Jie; Chen, Lijun; Sun, Weibing; Liu, Ben; Wang, Jingen; Meng, Qinggui; Wang, Dongwen; Hu, Zhiquan; He, Dalin; Yang, Yong; Song, Xishuang; Fu, Cheng; Wang, Yinhuai; Ye, Dingwei; Zhang, Wei 分享 收藏 分享 收藏 Identification of predictive factors for outcomes after robot-assisted partial nephrectomy based on three-dimensional reconstruction of preoperative enhanced computerized tomographyLi, Qinyu; Zhang, Yucong; Liu, Man; Li, Heng; Guan, Wei; Meng, Xiaoyan; Hu, Zhiquan; Wang, Zhihua; Wang, Shaogang; Li, Zhen; Liu, Jihong; Liu, Zheng 分享 收藏 Metabolic classifications of renal cell carcinoma reveal intrinsic connections with clinical and immune characteristicsLi, Le; Chao, Zheng; Waikeong, Un; Xiao, Jun; Ge, Yue; Wang, Yanan; Xiong, Zezhong; Ma, Sheng; Wang, Zhihua; Hu, Zhiquan; Zeng, Xing 分享 收藏 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
OAAI